Key result
Targeted LamC and bt silencing in Drosophila recapitulates hallmark features of DCM and HCM.
Why the study?
The functional consequences of many cardiomyopathy-associated genes and variants remain poorly defined, necessitating scalable in vivo models for precise cardiac phenotyping.
Does heart-specific knockdown of LamC and bt induce structural and functional phenotypes characteristic of dilated and hypertrophic cardiomyopathy in a Drosophila model?
Does heart-specific knockdown of LamC and bt induce structural and functional phenotypes characteristic of dilated and hypertrophic cardiomyopathy in a Drosophila model?
A scalable, segment-based in vivo Drosophila platform successfully recapitulates the structural and functional hallmarks of human dilated and hypertrophic cardiomyopathies, enabling future high-throughput functional validation of disease-associated variants.
Answers are grounded in this paper and cite their sources.
Supports Drosophila cardiomyopathy modeling; leaves open human translation pending mammalian validation.
Cardiomyopathies are major causes of heart failure and sudden cardiac death, yet the functional consequences of many disease-associated genes and variants remain poorly defined. Here, we establish a scalable, segment-based in vivo platform in Drosophila for quantitative cardiac phenotyping and precision modeling of cardiomyopathy subtypes. By integrating established cardiac imaging approaches into a standardized framework, termed Segmental Cardiac Output and Performance Evaluation (SCOPE), we systematically compared cardiac function across abdominal heart segments. This analysis identified segment A3 as the dominant pumping region, exhibiting the largest systolic and diastolic diameters, highest fractional shortening, and greatest cardiac output, thereby providing an optimal and reproducible site for functional assessment. Leveraging this platform, we generated genetically defined models of dilated and hypertrophic cardiomyopathy through heart-specific knockdown of LamC and bt , homologs of human LMNA and MYBPC3 , respectively. LamC silencing produced hallmark features of dilated cardiomyopathy, including chamber dilation, cardiomyocyte loss, reduced contractility, and decreased cardiac output. In contrast, bt silencing induced hypertrophic remodeling characterized by increased heart wall thickness and impaired cardiac performance. These models recapitulate key structural and functional characteristics of human cardiomyopathy subtypes. Together, this work establishes a scalable in vivo platform for segment-resolved cardiac phenotyping that enables precise modeling of cardiomyopathy, systematic functional validation of candidate genes and variants, and future discovery of genetic and pharmacologic modifiers.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2026) studied Dilated and hypertrophic cardiomyopathies (Drosophila model). Heart-specific knockdown of LamC and bt vs. Hand-Gal4/+ control flies was evaluated on Cardiac morphological and functional parameters (diastolic/systolic diameters, fractional shortening, stroke volume, cardiac output). Heart-specific silencing of LamC and bt in Drosophila induced hallmark structural and functional features of dilated and hypertrophic cardiomyopathies, establishing the A3 heart segment as an optimal site for functional modeling.
Synapse has enriched 10 related papers. Consider them for comparative context: